Menu Back toHow Can Real-World Evidence be Communicated Compliantly to Payers or Healthcare Providers?

DIA 2021 Global Annual Meeting


How Can Real-World Evidence be Communicated Compliantly to Payers or Healthcare Providers?

Session Chair(s)

Ruslan  Horblyuk, PhD, MA

Ruslan Horblyuk, PhD, MA

  • Chief Strategic Consulting Officer
  • AESARA, United States
This session will discuss the discourse on how real-world data could produce real-world evidence promotional communications to inform important treatment and access decisions and would meet the evidence standards of these two available FDA Guidances.
Learning Objective : Describe how real-world evidence should be designed, analyzed, and communicated compliantly to payers or healthcare providers; Discuss ways in which real-world data and real-world evidence could meet the evidence standard for compliant communications.

Speaker(s)

Stephen  Shinall, PhD

Industry Perspective

Stephen Shinall, PhD

  • Associate Director, Regulatory Affairs, US Advertising and Promotion
  • AbbVie, Inc., United States
Danny  Yeh, PhD

Industry Perspective

Danny Yeh, PhD

  • Senior Director, Health Policy and Systems Research, US Medical Affairs
  • Genentech, A Member of the Roche Group, United States
Alicia  Mack, PharmD

Industry Perspective

Alicia Mack, PharmD

  • Founder | and AESARA Consulting Partner
  • Aleysheya, LLC | and AESARA, United States